Cresco Labs Inc.: Business Overview, Financials & Competitive Analysis
Cresco Labs is a leader in cannabis cultivation, production and branded product distribution with a portfolio including Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy's and Remedi brands on a nat...
Cyborg Score thesis
Cresco holds strong branded assets and market position but faces near-term profitability challenges and debt constraints limiting...
Read the full analyst-debate transcript →Get the Latest Cresco Labs Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeCresco Labs Inc. Overview
Pro stress-test →Cresco Labs is a leader in cannabis cultivation, production and branded product distribution with a portfolio including Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy's and Remedi brands on a national level, and also operates highly productive dispensaries nationally under the Sunnyside brand. The company generated the entirety of its revenues from the United States but is now expanding internationally, with Q3 2025 revenues of $165 million declining 8% year-over-year.
Strategic Profile
Pro stress-test →Cresco recently announced its entry into Germany—its first expansion outside the United States—positioning itself in the largest medical cannabis market in Europe, currently valued at more than €670 million and expected to double over the next four years. The company remains largely exposed to ongoing U.S. market headwinds, including pricing pressure and regulatory uncertainty.
Competitive Landscape
Pro stress-test →Key competitors in the cannabis sector include Green Thumb Industries, Curaleaf Holdings, Trulieve Cannabis, Verano Holdings, and other multi-state operators competing in a saturated domestic market. The U.S. cannabis market remains saturated, highly regulated and increasingly competitive.
Industry Context
Cresco Labs Inc. operates in Cannabis Cultivation, Production & Distribution.
Key facts
Headquarters: Chicago, Illinois · Revenue: $0.67B